Based on a comparison of 9 firms among Czech Pharmaceutical Companies, Roche Czech Republic generated the highest net profit in 2017 followed by Bayer Czech Republic and Pfizer Czech Republic.
Roche Czech Republic made a net profit of CZK 252 mil, down 0% compared to the previous year. Historically, the firm’s net profit reached an all time high of CZK 252 mil in 2016 and an all time low of CZK 3.04 mil in 2003. The average profit in the last five years amounted to CZK 114 mil.
The company generated an average return on equity of 9.34% for its shareholders in the last five years with a maximum of 19.2% and a minimum of 3.57%.
Comparing Roche Czech Republic with its closest peers, Bayer Czech Republic generated a net profit of CZK 106 mil with a ROE of 27.2% in 2017, Pfizer Czech Republic netted CZK 103 mil (ROE of 7.86%) and Novartis Czech Republic announced a net profit of CZK 71.0 mil giving a ROE of 11.5%.
You can see all the companies net profit data on the Net Profit indicator page or you can download a special statistical dossier on the Czech Pharmaceutical Companies in the reports section.
Helgi Library 
